<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-25701" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Nephrocalcinosis</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Vaidya</surname>
            <given-names>Satyanarayana R.</given-names>
          </name>
          <aff>Emory University</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Yarrarapu</surname>
            <given-names>Siva Naga S.</given-names>
          </name>
          <aff>Monmouth Medical Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Aeddula</surname>
            <given-names>Narothama R.</given-names>
          </name>
          <aff>Deaconess HS, IN University School Med</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Satyanarayana Vaidya declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Siva Naga Yarrarapu declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Narothama Aeddula declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>8</day>
          <month>8</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-25701.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Nephrocalcinosis, a term first coined in 1934 by Fuller Albright, refers to augmented calcium content within the kidney which can be in the form of calcium oxalate or calcium phosphate. However, there have been suggestions that the definition of nephrocalcinosis should be limited to calcium phosphate deposition only and deposition of calcium oxalate should carry the name oxalosis. This activity reviews the cause and presentation of nephrocalcinosis and highlights the role of the interprofessional team in its management.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the etiology of nephrocalcinosis.</p></list-item><list-item><p>Review the investigation of a patient with nephrocalcinosis..</p></list-item><list-item><p>Outline the treatment and management options available for nephrocalcinosis.</p></list-item><list-item><p>Describe some interprofessional team strategies for improving care coordination and outcomes in patients with nephrocalcinosis.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=25701&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=25701">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-25701.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Nephrocalcinosis, a&#x000a0;term first coined in 1934 by Fuller Albright, refers to augmented calcium content within the kidney which can be in the form of calcium oxalate or calcium phosphate.<xref ref-type="bibr" rid="article-25701.r1">[1]</xref> However, there have been suggestions that the definition of nephrocalcinosis should&#x000a0;be limited to calcium phosphate deposition only and deposition of calcium oxalate should carry the name oxalosis.<xref ref-type="bibr" rid="article-25701.r2">[2]</xref> The condition demonstrates characteristic deposition of calcium in the kidney parenchyma and tubules. It can be incidentally detected in a radiograph from a patient with normal kidney function or present with an acute or chronic kidney injury. Many conditions lead to this entity, and the overall renal prognosis depends on the underlying causative condition causing.</p>
      </sec>
      <sec id="article-25701.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Nephrocalcinosis refers to generalized calcium deposition in the kidney and does not include the focal calcium deposition associated with focal renal injury. It is caused by diseases that cause hypercalcemia, hyperphosphatemia, hypercalciuria, hyperphosphaturia, and hyperoxaluria.</p>
        <p>Calcium phosphate crystal formation occurs in alkaline urine pH. It has associations with many diseases which operate through the underlying mechanisms.</p>
        <list list-type="bullet">
          <list-item>
            <p>Hypercalciuria with hypercalcemia</p>
          </list-item>
          <list-item>
            <p>Hypercalciuria without hypercalcemia</p>
          </list-item>
          <list-item>
            <p>Hyper-phosphaturia with hyperphosphatemia</p>
          </list-item>
          <list-item>
            <p>Hyper-phosphaturia without hyperphosphatemia</p>
          </list-item>
        </list>
        <p>
<bold>1.&#x000a0;Conditions causing both hypercalcemia and hypercalciuria</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Primary hyperparathyroidism</p>
          </list-item>
          <list-item>
            <p>Vitamin D therapy</p>
          </list-item>
          <list-item>
            <p>Sarcoidosis</p>
          </list-item>
          <list-item>
            <p>Milk-alkali syndrome</p>
          </list-item>
          <list-item>
            <p>Congenital hypothyroidism</p>
          </list-item>
        </list>
        <p>
<bold>2. Conditions causing hypercalciuria without hypercalcemia</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Distal renal tubular acidosis</p>
          </list-item>
          <list-item>
            <p>Medullary sponge kidney</p>
          </list-item>
          <list-item>
            <p>Neonatal nephrocalcinosis and loop diuretics</p>
          </list-item>
          <list-item>
            <p>Inherited tubulopathies</p>
          </list-item>
          <list-item>
            <p>Chronic hypokalemia</p>
          </list-item>
          <list-item>
            <p>Beta thalassemia</p>
          </list-item>
        </list>
        <p>
<bold>3. Conditions causing Hyper-phosphaturia and hyperphosphatemia</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Tumor lysis syndrome</p>
          </list-item>
          <list-item>
            <p>Oral sodium phosphate bowel preparations</p>
          </list-item>
        </list>
        <p>
<bold>4. Conditions causing Hyper-phosphaturia without hyperphosphatemia</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Inherited tubulopathies such as Dent disease, Lowe syndrome</p>
          </list-item>
          <list-item>
            <p>X-linked, autosomal dominant, and autosomal recessive hypophosphatemic rickets.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-25701.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>
<bold>Primary Hyperparathyroidism</bold>
</p>
        <p>Nephrocalcinosis and nephrolithiasis are the most common renal manifestations of primary hyperparathyroidism.<xref ref-type="bibr" rid="article-25701.r3">[3]</xref>&#x000a0;Nephrocalcinosis has&#x000a0;been reported&#x000a0;in up to 22% of cases of primary hyperparathyroidism.<xref ref-type="bibr" rid="article-25701.r4">[4]</xref> Although parathyroid hormone stimulates the distal tubular reabsorption of calcium, the effect is overshadowed by the increase in filtered calcium thereby,&#x000a0;increasing the urinary calcium excretion.</p>
        <p>
<bold>Sarcoidosis</bold>
</p>
        <p>Sarcoidosis is associated with hypercalcemia and hypercalciuria. Nephrocalcinosis is seen in up to 50% of cases with renal involvement.</p>
        <p>
<bold>Hypervitaminosis D</bold>
</p>
        <p>Vitamin D acts by increasing the intestinal absorption of calcium and also bone resorption, which results in hypercalcemia and hypercalciuria. Nephrocalcinosis is more likely to occur when activated vitamin D such as calcitriol in conjunction&#x000a0;with phosphate supplements. This scenario is common in X-linked hypophosphatemic rickets.<xref ref-type="bibr" rid="article-25701.r5">[5]</xref> Children with nephropathic cystinosis excrete large amounts of calcium and phosphate due to renal tubular Fanconi syndrome and also receive substantial supplements of phosphate and alkalinizing agents. In a study by Theodoropoulos et al., it was found that out of 41 children with nephropathic cystinosis, 18 had mild nephrocalcinosis and 8 had severe nephrocalcinosis. The authors also concluded that nephrocalcinosis in such situations is best managed by reducing the oral replacement of calcium, phosphate, vitamin D, and citrate.<xref ref-type="bibr" rid="article-25701.r6">[6]</xref></p>
        <p>
<bold>Distal Renal Tubular Acidosis</bold>
</p>
        <p>It is the most common cause of nephrocalcinosis due to hypercalciuria without hypercalcemia. It has associations with hypocitraturia, which promotes calcium precipitation in renal tubules. It also results in metabolic acidosis which causes increased buffering of acid by bone buffers with subsequent release of calcium and phosphate. In a study by Brenner et al., evaluating the radiological prevalence of nephrocalcinosis in various renal tubular acidosis, of the 92 patients studied, nephrocalcinosis&#x000a0;was seen in up to 29% of patients who were predominantly those with distal renal tubular acidosis.<xref ref-type="bibr" rid="article-25701.r7">[7]</xref></p>
        <p>
<bold>Medullary Sponge Kidney</bold>
</p>
        <p>This condition is a disorder with dilated papillary collecting ducts, and stones are common. It is associated with hypercalciuria and hypocitraturia thereby,&#x000a0;resulting in nephrocalcinosis.<xref ref-type="bibr" rid="article-25701.r8">[8]</xref> In a study by Yendt et al., nephrocalcinosis was observed in up to 50% of cases of the medullary sponge kidney.<xref ref-type="bibr" rid="article-25701.r9">[9]</xref></p>
        <p>
<bold>Nephrocalcinosis Due To</bold>
<bold>&#x000a0;Loop Diuretic Abuse</bold>
</p>
        <p>There is a risk of nephrocalcinosis in patients taking high doses of loop diuretics for a prolonged period. In a study by Kim et al., 18 consecutive adult patients who habitually took furosemide for weight gain and edema were evaluated. The study found nephrocalcinosis in 15 patients that underwent exposure to a mean dose of 538 mg per day. The authors concluded that the risk of nephrocalcinosis correlates with the dose of furosemide taken.<xref ref-type="bibr" rid="article-25701.r10">[10]</xref></p>
        <p>
<bold>Hereditary Disorders Associated with Nephrocalcinosis</bold>
</p>
        <p>Some of these include X-linked hypercalciuric nephrolithiasis, X-linked hypophosphatemic rickets, hypomagnesemia-hypercalciuria syndrome, and Bartter syndrome.</p>
        <p>X-linked hypercalciuric nephrolithiasis is also termed Dent disease and has associations with some mutations affecting the CLCN5 gene on the X chromosome that leads to inactivation of CLC-5 voltage-gated chloride channels. This results in a clinical syndrome affecting young boys and usually includes hypercalciuria, nephrocalcinosis, nephrolithiasis, hematuria, low molecular weight proteinuria, glycosuria, aminoaciduria, hypophosphatemia, renal failure, and rickets.<xref ref-type="bibr" rid="article-25701.r11">[11]</xref></p>
      </sec>
      <sec id="article-25701.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Nephrocalcinosis falls into the following classifications:</p>
        <p><italic toggle="yes">Molecular or chemical</italic>: an increase in intracellular calcium concentration which is quantifiable but not microscopically or radiologically visible</p>
        <p><italic toggle="yes">Microscopic</italic>: Deposits visible by light microscopic examination of kidney biopsy specimen but not radiologically visible</p>
        <p><italic toggle="yes">Macroscopic</italic>: calcification visible radiologically</p>
        <p>It usually involves the renal medulla and much less often the cortex.&#x000a0;</p>
        <p>Conditions associated with cortical nephrocalcinosis are:</p>
        <list list-type="bullet">
          <list-item>
            <p>Cortical necrosis such as occurs in pregnancy</p>
          </list-item>
          <list-item>
            <p>Transplant rejection</p>
          </list-item>
          <list-item>
            <p>Chronic glomerulonephritis</p>
          </list-item>
          <list-item>
            <p>Trauma</p>
          </list-item>
          <list-item>
            <p>Tuberculosis</p>
          </list-item>
          <list-item>
            <p>Oxalosis</p>
          </list-item>
        </list>
        <p>Oxalosis is one condition which can cause both medullary and cortical nephrocalcinosis.</p>
        <p>The most common cause of nephrocalcinosis is hypercalciuria with or without hypercalcemia. The metabolic abnormalities of hypercalciuria, hyperphosphaturia, and hyperoxaluria are often associated with nephrolithiasis and patients often present with both conditions. Calcium phosphate and calcium oxalate crystals form when the concentration of the solutes exceed the saturation limit in the tubular fluid. In a study by Evan AP et al., Randall's plaques were noted in the inner medullary interstitium as part of the basement membranes of the thin limb of the loop of Henle where the tubular fluid is saturated.<xref ref-type="bibr" rid="article-25701.r12">[12]</xref> Once these calcium phosphate plaques form, they can enlarge into the surrounding interstitial tissue or rupture into the tubular lumen subsequently forming a nidus for luminal calcium oxalate stone.</p>
        <p>Light microscopy in nephrocalcinosis shows intracellular, tubular, and interstitial basophilic calcifications. Calcium phosphate deposition is accompanied by lymphocyte predominant interstitial infiltrate and interstitial fibrosis.</p>
      </sec>
      <sec id="article-25701.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Nephrocalcinosis most commonly presents as asymptomatic, chronic disease process discovered on radiographic imaging of abdomen. However, ordering radiographs might be feasible due to the evaluation of pain caused by coexisting nephrolithiasis. Nephrolithiasis can occur due to chronic hypercalcemia and hypercalciuria. It can cause renal colic. Polyuria and polydipsia can occur with chronic hypercalcemia, medullary nephrocalcinosis, and in Bartter syndrome.</p>
        <p>It can also present acutely with renal failure in instances such as tumor lysis syndrome and acute phosphate nephropathy.</p>
      </sec>
      <sec id="article-25701.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Once the radiologic determination of nephrocalcinosis has taken place, the causal investigation should follow. Serum electrolytes, calcium, phosphate should be measured. Measurement of urine pH should help determine the presence of&#x000a0;distal renal tubular acidosis. Besides&#x000a0;the above, the recommendation is to obtain two 24 hour urine collections for measuring the excretion of calcium, phosphate, oxalate, citrate, and creatinine.</p>
      </sec>
      <sec id="article-25701.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Treatment is directed to treat the underlying cause of nephrocalcinosis. Strategies to reduce the urinary concentration of calcium, phosphate, or oxalate are used. Fluid intake is increased to produce at least 2 Liters of urine a day.</p>
        <p>Among patients with hypercalciuria, urinary calcium excretion can be reduced by restricting the amount of animal protein, decreasing the sodium intake to less than 100 milliequivalents /day, increasing the potassium intake, and using a thiazide diuretic to reduce the urinary calcium excretion. However, patients with hypercalcemia should not use a thiazide diuretic.</p>
        <p>In&#x000a0;nephrocalcinosis due to&#x000a0;distal renal tubular acidosis, potassium citrate is used in patients with hypocitraturia and pH less than 7. This not only replenishes the potassium loss but also achieves a normal urinary citrate level, thereby&#x000a0;increasing the solubility of calcium.</p>
      </sec>
      <sec id="article-25701.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Cortical nephrocalcinosis is typically the result of dystrophic calcification, which occurs subsequent to parenchymal tissue destruction rather than the precipitation of excessive urinary constituents. The causes include infarction, malignancy, and infection.</p>
      </sec>
      <sec id="article-25701.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Specific causes of nephrocalcinosis such as Dent disease, primary hyperoxaluria, and hypomagnesemic hypercalciuric nephrocalcinosis, if not treated effectively, would progress to chronic renal failure,<xref ref-type="bibr" rid="article-25701.r13">[13]</xref>&#x000a0;End Stage Renal Disease. Nephrocalcinosis once detected radiologically is rarely reversible.</p>
      </sec>
      <sec id="article-25701.s11" sec-type="Complications">
        <title>Complications</title>
        <p>X-linked hypophosphatemic rickets if not treated appropriately will cause stunted bone growth. In hypomagnesemia-hypercalciuria syndrome children can present with tetanic seizures, muscle cramps, and weakness. In a subset of patients, sensorineural hearing loss and ocular impairment can occur.</p>
      </sec>
      <sec id="article-25701.s12" sec-type="Consultations">
        <title>Consultations</title>
        <p>Nephrology</p>
        <p>Urology</p>
        <p>Pediatrics</p>
      </sec>
      <sec id="article-25701.s13" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patients with nephrocalcinosis should be instructed to drink adequate water intake to&#x000a0;maintain a urine volume of at least 2 liters/day. Patients need instruction to limit dietary protein intake in hypercalciuria, limit the daily sodium intake to less than 100 milliequivalents /day.</p>
      </sec>
      <sec id="article-25701.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Knowledge of both the systemic and renal-specific causes of nephrocalcinosis is required as it will help to identify the primary lesion,&#x000a0;whether it is genetic or acquired. It is vital to determine the underlying etiology for the nephrocalcinosis as only some causes will lead to chronic kidney disease and subsequently&#x000a0;end-stage renal failure. Co-ordination between pediatrics, internal medicine and nephrology is needed&#x000a0;to diagnose the primary etiology for early management.&#x000a0;</p>
      </sec>
      <sec id="article-25701.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=25701&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=25701">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/kidney-health/nephrocalcinosis/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=25701">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/25701/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=25701">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-25701.s16">
        <fig id="article-25701.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Renal Ultrasound, Medullary Nephrocalcinosis Contributed by Scott Dulebohn, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="medullary__nephro__Ca" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-25701.s17">
        <fig id="article-25701.image.f2" position="float" orientation="portrait">
          <caption>
            <p>Nephrocalcinosis Image courtesy S Bhimji MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="nephrocalcinosis" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-25701.s18">
        <title>References</title>
        <ref id="article-25701.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sayer</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Carr</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Simmons</surname>
                <given-names>NL</given-names>
              </name>
            </person-group>
            <article-title>Nephrocalcinosis: molecular insights into calcium precipitation within the kidney.</article-title>
            <source>Clin Sci (Lond)</source>
            <year>2004</year>
            <month>Jun</month>
            <volume>106</volume>
            <issue>6</issue>
            <fpage>549</fpage>
            <page-range>549-61</page-range>
            <pub-id pub-id-type="pmid">15027893</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25701.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Markowitz</surname>
                <given-names>GS</given-names>
              </name>
              <name>
                <surname>Nasr</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Klein</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Anderson</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Stack</surname>
                <given-names>JI</given-names>
              </name>
              <name>
                <surname>Alterman</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Price</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Radhakrishnan</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>D'Agati</surname>
                <given-names>VD</given-names>
              </name>
            </person-group>
            <article-title>Renal failure due to acute nephrocalcinosis following oral sodium phosphate bowel cleansing.</article-title>
            <source>Hum Pathol</source>
            <year>2004</year>
            <month>Jun</month>
            <volume>35</volume>
            <issue>6</issue>
            <fpage>675</fpage>
            <page-range>675-84</page-range>
            <pub-id pub-id-type="pmid">15188133</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25701.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Suh</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Cronan</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Monchik</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Primary hyperparathyroidism: is there an increased prevalence of renal stone disease?</article-title>
            <source>AJR Am J Roentgenol</source>
            <year>2008</year>
            <month>Sep</month>
            <volume>191</volume>
            <issue>3</issue>
            <fpage>908</fpage>
            <page-range>908-11</page-range>
            <pub-id pub-id-type="pmid">18716127</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25701.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lloyd</surname>
                <given-names>HM</given-names>
              </name>
            </person-group>
            <article-title>Primary hyperparathyroidism: an analysis of the role of the parathyroid tumor.</article-title>
            <source>Medicine (Baltimore)</source>
            <year>1968</year>
            <month>Jan</month>
            <volume>47</volume>
            <issue>1</issue>
            <fpage>53</fpage>
            <page-range>53-71</page-range>
            <pub-id pub-id-type="pmid">4866142</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25701.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Verge</surname>
                <given-names>CF</given-names>
              </name>
              <name>
                <surname>Lam</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Simpson</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Cowell</surname>
                <given-names>CT</given-names>
              </name>
              <name>
                <surname>Howard</surname>
                <given-names>NJ</given-names>
              </name>
              <name>
                <surname>Silink</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Effects of therapy in X-linked hypophosphatemic rickets.</article-title>
            <source>N Engl J Med</source>
            <year>1991</year>
            <month>Dec</month>
            <day>26</day>
            <volume>325</volume>
            <issue>26</issue>
            <fpage>1843</fpage>
            <page-range>1843-8</page-range>
            <pub-id pub-id-type="pmid">1660098</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25701.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Theodoropoulos</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Shawker</surname>
                <given-names>TH</given-names>
              </name>
              <name>
                <surname>Heinrichs</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Gahl</surname>
                <given-names>WA</given-names>
              </name>
            </person-group>
            <article-title>Medullary nephrocalcinosis in nephropathic cystinosis.</article-title>
            <source>Pediatr Nephrol</source>
            <year>1995</year>
            <month>Aug</month>
            <volume>9</volume>
            <issue>4</issue>
            <fpage>412</fpage>
            <page-range>412-8</page-range>
            <pub-id pub-id-type="pmid">7577398</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25701.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brenner</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Spring</surname>
                <given-names>DB</given-names>
              </name>
              <name>
                <surname>Sebastian</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>McSherry</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Genant</surname>
                <given-names>HK</given-names>
              </name>
              <name>
                <surname>Palubinskas</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Morris</surname>
                <given-names>RC</given-names>
              </name>
            </person-group>
            <article-title>Incidence of radiographically evident bone disease, nephrocalcinosis, and nephrolithiasis in various types of renal tubular acidosis.</article-title>
            <source>N Engl J Med</source>
            <year>1982</year>
            <month>Jul</month>
            <day>22</day>
            <volume>307</volume>
            <issue>4</issue>
            <fpage>217</fpage>
            <page-range>217-21</page-range>
            <pub-id pub-id-type="pmid">7088070</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25701.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Parks</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Coe</surname>
                <given-names>FL</given-names>
              </name>
              <name>
                <surname>Strauss</surname>
                <given-names>AL</given-names>
              </name>
            </person-group>
            <article-title>Calcium nephrolithiasis and medullary sponge kidney in women.</article-title>
            <source>N Engl J Med</source>
            <year>1982</year>
            <month>May</month>
            <day>06</day>
            <volume>306</volume>
            <issue>18</issue>
            <fpage>1088</fpage>
            <page-range>1088-91</page-range>
            <pub-id pub-id-type="pmid">7070404</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25701.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yendt</surname>
                <given-names>ER</given-names>
              </name>
            </person-group>
            <article-title>Medullary sponge kidney and nephrolithiasis.</article-title>
            <source>N Engl J Med</source>
            <year>1982</year>
            <month>May</month>
            <day>06</day>
            <volume>306</volume>
            <issue>18</issue>
            <fpage>1106</fpage>
            <page-range>1106-7</page-range>
            <pub-id pub-id-type="pmid">7070408</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25701.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kim</surname>
                <given-names>YG</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>Chung</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Han</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Ryu</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>YH</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>KB</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>JY</given-names>
              </name>
              <name>
                <surname>Huh</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Oh</surname>
                <given-names>HY</given-names>
              </name>
            </person-group>
            <article-title>Medullary nephrocalcinosis associated with long-term furosemide abuse in adults.</article-title>
            <source>Nephrol Dial Transplant</source>
            <year>2001</year>
            <month>Dec</month>
            <volume>16</volume>
            <issue>12</issue>
            <fpage>2303</fpage>
            <page-range>2303-9</page-range>
            <pub-id pub-id-type="pmid">11733620</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25701.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Scheinman</surname>
                <given-names>SJ</given-names>
              </name>
            </person-group>
            <article-title>X-linked hypercalciuric nephrolithiasis: clinical syndromes and chloride channel mutations.</article-title>
            <source>Kidney Int</source>
            <year>1998</year>
            <month>Jan</month>
            <volume>53</volume>
            <issue>1</issue>
            <fpage>3</fpage>
            <page-range>3-17</page-range>
            <pub-id pub-id-type="pmid">9452994</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25701.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Evan</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>Lingeman</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Coe</surname>
                <given-names>FL</given-names>
              </name>
              <name>
                <surname>Parks</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Bledsoe</surname>
                <given-names>SB</given-names>
              </name>
              <name>
                <surname>Shao</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Sommer</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Paterson</surname>
                <given-names>RF</given-names>
              </name>
              <name>
                <surname>Kuo</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Grynpas</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Randall's plaque of patients with nephrolithiasis begins in basement membranes of thin loops of Henle.</article-title>
            <source>J Clin Invest</source>
            <year>2003</year>
            <month>Mar</month>
            <volume>111</volume>
            <issue>5</issue>
            <fpage>607</fpage>
            <page-range>607-16</page-range>
            <pub-id pub-id-type="pmid">12618515</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25701.r13">
          <label>13</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Vaidya</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Aeddula</surname>
                <given-names>NR</given-names>
              </name>
            </person-group>
            <chapter-title>Chronic Kidney Disease</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2024</year>
            <month>7</month>
            <day>31</day>
            <pub-id pub-id-type="pmid">30571025</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
